Advertisements



Morgan Stanley says generic Advair delay a small negative for Mylan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Advair generic delay negative news for Mylan, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Morgan Stanley downgrades Mylan to Equal Weight on generic, Epipen uncertainty

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Morgan Stanley says Mylan Advair news likely seen as positive for Innoviva

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Mylan to recover from "modest" generic Advair delay, says Mizuho

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Mylan to have only a "minor" delay to generic Advair approval, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Mylan downgraded to equal weight from overweight at Morgan Stanley

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 9th, 2018

3 Headwinds Hindering Mylan

Even with positive near-term catalysts, Mylan NV (NASDAQ: MYL) suffers from “uncertain prospects” that warrant a neutral stance, according to Morgan Stanley.  Latest Ratings for M.....»»

Category: blogSource: benzingaOct 9th, 2018

Mylan downgraded to Equal Weight from Overweight at Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Morgan Stanley Is Buying Up a Pair of Small Stocks

The bank took big stakes in a real-estate investment trust in the state of liquidating and a medical-services firm......»»

Category: topSource: barronsOct 6th, 2018

Syndax delay likely to disappoint investors, says Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2018

The Tell: Morgan Stanley upgrades emerging-market currencies as U.S. stocks outperform

Strategists at Morgan Stanley on Monday raise their rating on emerging-market currencies and bonds to neutral from negative, in part because global risks are more moderate than projected......»»

Category: topSource: marketwatchSep 24th, 2018

Tesla may find it a challenge to remain an independent company, analyst says

Tesla may find itself in need of a partner in the next few months, and whether that would be a positive or a negative for investors remains to be seen, analysts at Morgan Stanley say......»»

Category: topSource: marketwatchSep 19th, 2018

AT&T Should Have Good Things to Say When It Finally Dishes on Time Warner

Morgan Stanley is betting on no negative surprises when the telecom giant holds an analyst event in November......»»

Category: topSource: barronsSep 12th, 2018

Morgan Stanley Is Buying These Two Small Stocks Now

Morgan Stanley now holds stakes of more than 5% in two small companies: Electronics for Imaging and Turtle Beach......»»

Category: blogSource: barronsAug 23rd, 2018

AT&T stock discounting "overly negative" outlook, says Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2018

Cytokinetics Downgraded On Data Delay

Biopharma Cytokinetics Inc. (NASDAQ: CYTK) announced a delay in drug studies during its earnings call Thursday, prompting a downgrade by Morgan Stanley.  Latest Ratings for CYTK DateFirmAction.....»»

Category: blogSource: benzingaAug 1st, 2018

Even minor delays can hurt Mylan"s generic Advair opportunity, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Morgan Stanley Initiates Amneal Pharmaceuticals, Anticipates Outperformance

Amneal Pharmaceuticals (NYSE: AMRX) announced Monday the FDA approval of its newest drug, a generic version of Potassium Chloride oral solution. Latest Ratings for AMRX .....»»

Category: blogSource: benzingaJul 23rd, 2018

Morgan Stanley: "It"s Not Your Imagination, Large Moves Are Becoming More Common In The Market"

Exactly two months ago, Goldman joined the relatively small group of voices warning that t.....»»

Category: blogSource: zerohedgeJul 22nd, 2018

Negative gaming data for Nvidia largely backward looking, says Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018